Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3249034
Max Phase: Preclinical
Molecular Formula: C48H68N16O9
Molecular Weight: 1013.17
Molecule Type: Protein
Associated Items:
ID: ALA3249034
Max Phase: Preclinical
Molecular Formula: C48H68N16O9
Molecular Weight: 1013.17
Molecule Type: Protein
Associated Items:
Canonical SMILES: CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](Cc1ccc(N=[N+]=[N-])cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
Standard InChI: InChI=1S/C48H68N16O9/c1-27(2)39(60-41(66)33(56-38(65)25-52-5)13-9-19-54-48(49)50)44(69)57-34(21-30-15-17-31(18-16-30)62-63-51)42(67)61-40(28(3)4)45(70)58-35(23-32-24-53-26-55-32)46(71)64-20-10-14-37(64)43(68)59-36(47(72)73)22-29-11-7-6-8-12-29/h6-8,11-12,15-18,24,26-28,33-37,39-40,52H,9-10,13-14,19-23,25H2,1-5H3,(H,53,55)(H,56,65)(H,57,69)(H,58,70)(H,59,68)(H,60,66)(H,61,67)(H,72,73)(H4,49,50,54)/t33-,34+,35-,36-,37-,39-,40-/m0/s1
Standard InChI Key: LGGLWQKEAGHNMX-HYFOLETESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1013.17 | Molecular Weight (Monoisotopic): 1012.5355 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Hsieh K, Kiraly-Olah IC, Jorgensen EC, Lee TC.. (1979) Angiotensin II analogues. 13. Role of the hydroxyl group of position 4 tyrosine in pressor activity., 22 (9): [PMID:490549] [10.1021/jm00195a008] |
Source(1):